Creative Biolabs is the leading custom service provider with extensive experience in various antibody production and engineering fields.
Creative biolabs has developed Lentiviral CAR vector pCDCAR1 CD45 (4122) h(ICOSBB_), which is constructed for the engineering of T cells to target human CD45. The T cells are genetically modified through transduction with a Lentiviral vector expressing scFv of anti-CD45 antibody linked to a CD28 transmembrane domain/ endodomain and OX40, CD3-zeta signaling domains. And the vector product was designed for the treatment of autoimmune disease.
Creative Biolabs is the leading custom service provider with extensive experience in various antibody production and engineering fields.